Generation Bio

Generation Bio EV/OCF

Delisted

The EV/OCF (Enterprise Value to Operating Cash Flow) of Generation Bio (GBIO) as of Nov 10, 2026 is 1.69. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 4.33 — a change of -61.08% (lower).

EV/OCF

1.69

YoY

-61.08%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Generation Bio is 2024 1.69 . EV/OCF (Enterprise Value to Operating Cash Flow) of Generation Bio was 2023 4.33 . It decreases by -61.08% lower compared to the previous year.

The Generation Bio EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
1.38 USD
Jan 1, 2019
-0.52 USD
Jan 1, 2020
3.23 USD
Jan 1, 2021
3.69 USD
Jan 1, 2022
2.37 USD
Jan 1, 2023
4.33 USD
Jan 1, 2024
1.69 USD
The Generation Bio EV/OCF history
YEAREV/OCFYoY
1.69-61.08%
4.33+82.47%
2.37-35.76%
3.69+14.46%
3.23-722.81%
-0.52-137.46%
1.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Generation Bio Stock analysis

What does Generation Bio do? Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts, that focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The firm is developing a class of gene therapy utilizing its non-viral gene therapy platform to deliver genetic payloads to a range of tissues. The company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The firm is engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The firm is a preclinical stage company and have not identified a product candidate. Generation Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Generation Bio stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Generation Bio is 1.69 in 2024.

EV/OCF (Enterprise Value to Operating Cash Flow) of Generation Bio changed from 4.33 to 1.69, representing a -61.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Generation Bio since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Generation Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Generation Bio

All Key Metrics — Generation Bio